浏览全部资源
扫码关注微信
1.华中科技大学同济医学院附属武汉金银潭医院(湖北省传染病临床医学研究中心)消化科,武汉;430023
2.华中科技大学同济医学院附属武汉金银潭医院(湖北省传染病临床医学研究中心)感染科,武汉 430023
Received:12 October 2024,
Revised:08 February 2025,
Accepted:2025-02-10,
Published:15 April 2025
移动端阅览
吴霜,程海林,刘丹等.二甲双胍对非酒精性脂肪性肝炎大鼠肝损伤的改善作用 Δ[J].中国药房,2025,36(07):837-842.
WU Shuang,CHENG Hailin,LIU Dan,et al.Improvement effect of metformin on liver injury in non-alcoholic steatohepatitis rats[J].ZHONGGUO YAOFANG,2025,36(07):837-842.
吴霜,程海林,刘丹等.二甲双胍对非酒精性脂肪性肝炎大鼠肝损伤的改善作用 Δ[J].中国药房,2025,36(07):837-842. DOI: 10.6039/j.issn.1001-0408.2025.07.12.
WU Shuang,CHENG Hailin,LIU Dan,et al.Improvement effect of metformin on liver injury in non-alcoholic steatohepatitis rats[J].ZHONGGUO YAOFANG,2025,36(07):837-842. DOI: 10.6039/j.issn.1001-0408.2025.07.12.
目的
2
探究二甲双胍(Met)调控磷脂酰肌醇3激酶/蛋白激酶B/血小板源性生长因子(PI3K/AKT/PDGF)信号通路对非酒精性脂肪性肝炎(NASH)大鼠肝损伤的影响。
方法
2
以高糖高脂饮食饲喂大鼠构建NASH模型,造模成功后随机分为模型组(Model组)、Met低剂量组(Met-L组,100 mg/kg)、Met中剂量组(Met-M组,200 mg/kg)、Met高剂量组(Met-H组,400 mg/kg)、高剂量Met+PI3K激活剂组(Met-H+740 Y-P组,400 mg/kg Met+50 mg/kg 740 Y-P),另设对照组(Control组),每组12只。各组大鼠每天灌胃/注射相应药物1次,连续6周。分析大鼠体重和肝指数变化;观察大鼠肝组织病理损伤[评估非酒精性脂肪性肝病活动度评分(NAS)]、脂质沉积(计算油红O阳性染色面积占比)和纤维化(计算胶原沉积分数)情况;检测大鼠血清和肝组织中炎症因子[白细胞介素6(IL-6)、肿瘤坏死因子α(TNF-α)]水平以及血清中脂代谢[总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)]和肝功能[天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)]指标水平;检测大鼠肝组织中PI3K/AKT/PDGF信号通路相关蛋白和胱天蛋白酶3(Caspase-3)蛋白表达水平。
结果
2
与Control组比较,Model组大鼠体重和肝指数,血清中脂代谢和肝功能指标水平,血清和肝组织中IL-6、TNF-α水平,NAS,油红O阳性染色面积占比,胶原沉积分数,肝组织中PI3K、AKT蛋白磷酸化水平和PDGF、Caspase-3蛋白表达水平均显著升高(
P
<0.05);肝组织病理损伤严重,富含脂滴,胶原沉积明显。经Met干预后,大鼠上述定量指标和病理变化均显著改善(
P
<0.05),且呈剂量依赖性(
P
<0.05)。740 Y-P可显著逆转高剂量Met对大鼠上述指标的改善作用(
P
<0.05)。
结论
2
Met可改善NASH大鼠肝损伤,减轻炎症反应和肝纤维化,其作用机制可能与抑制PI3K/AKT/PDGF信号通路活性有关。
OBJECTIVE
2
To investigate the effects of metformin (Met) on liver injury in non-alcoholic steatohepatitis (NASH) rats by regulating the PI3K/AKT/PDGF signaling pathway.
METHODS
2
NASH model was constructed by feeding rats with a high-glucose and high-fat diet, and assigned into Model group, Met low-dose group (Met-L group, 100 mg/kg), Met medium-dose group (Met-M group, 200 mg/kg), Met high-dose group (Met-H group, 400 mg/kg), and high dose of Met+PI3K activator group (Met-H+740 Y-P group, 400 mg/kg Met+50 mg/kg 740 Y-P), with 12 rats in each group. Another 12 rats were regarded as the Control group. Each group of rats was orally administered/injected with the corresponding medication once a day for 6 consecutive weeks. The changes in body weight and liver index of rats were recorded and analyzed. The pathological damage [evaluation of non-alcoholic fatty liver disease activity score (NAS)], lipid deposition (calculation of the proportion of oil red O-positive staining area), and fibrosis (calculation of collagen deposition score) were observed in liver tissue of rats. The levels of inflammatory factors [interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α)] in serum and liver tissue, the levels of serum lipid metabolism indicators [total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C)] and liver function indicators [aspartate aminotransferase (AST) and alanine aminotransferase (ALT)] were measured. The expression levels of PI3K/AKT/PDGF signaling pathway-related proteins and Caspase-3 in liver tissue of rats were determined.
RESULTS
2
Compared with the Control group, body weight, liver index, the levels of serum lipid metabolism indicators and liver function indicators, the levels of IL-6 and TNF-α in serum and liver tissue, the NAS, the proportion of oil red O-positive staining area, the collagen deposition fraction, and the levels of phosphorylated PI3K and AKT proteins, as well as the expression levels of PDGF and Caspase-3 proteins in liver tissue, were all significantly increased (
P
<0.05). The liver tissue showed severe pathological damage, characterized by an abundance of lipid droplets and pronounced collagen deposition. After the intervention with Met, the aforementioned quantitative indicators and pathological changes in rats were significantly improved in a dose-dependent manner (
P
<0.05). 740 Y-P could reverse the improvement effects of high dose of Met on the above indexes of rats (
P
<0.05).
CONCLUSIONS
2
Met can improve liver damage, and alleviate inflammatory reactions and liver fibrosis of NASH rats, the mechanism of which may be associated with inhibiting PI3K/AKT/PDGF signaling pathway.
LIN Z B , YANG P J , HU Y F , et al . Ring finger protein 13 protects against nonalcoholic steatohepatitis by targeting STING-relayed signaling pathways [J ] . Nat Commun , 2023 , 14 ( 1 ): 6635 .
XU X H , POULSEN K L , WU L J , et al . Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) [J ] . Signal Transduct Target Ther , 2022 , 7 ( 1 ): 287 .
FORETZ M , GUIGAS B , VIOLLET B . Metformin:update on mechanisms of action and repurposing potential [J ] . Nat Rev Endocrinol , 2023 , 19 ( 8 ): 460 - 476 .
李瑞芳 , 卜淑蕊 . 二甲双胍对高脂饮食诱导的非酒精性脂肪性肝病大鼠肠道菌群的影响 [J ] . 中华消化杂志 , 2020 , 40 ( 12 ): 861 - 867 .
SONG H , ZHANG X J , ZHAI R Q , et al . Metformin attenuated sepsis-associated liver injury and inflammatory response in aged mice [J ] . Bioengineered , 2022 , 13 ( 2 ): 4598 - 4609 .
吕春卉 , 李大炜 , 王小洁 , 等 . 二甲双胍联合辛伐他汀治疗非酒精性脂肪性肝病合并2型糖尿病患者疗效研究 [J ] . 实用肝脏病杂志 , 2022 , 25 ( 1 ): 50 - 53 .
YU Y J , ZHOU S Z , WANG Y , et al . Leonurine alleviates acetaminophen-induced acute liver injury by regulating the PI3K/AKT signaling pathway in mice [J ] . Int Immunopharmacol , 2023 , 120 : 110375 .
XU X Y , GENG Y , XU H X , et al . Antrodia camphorata -derived antrodin C inhibits liver fibrosis by blocking TGF-beta and PDGF signaling pathways [J ] . Front Mol Biosci , 2022 , 9 : 835508 .
YE Q , LIU Y , ZHANG G J , et al . Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K/AKT/PDGF axis activation in male mice [J ] . Nat Commun , 2023 , 14 ( 1 ): 1402 .
EMAN E , HEMAT E , HANAA H , et al . Effects of berberine on high-fat/high-sucrose-induced nonalcoholic steatohepatitis in experimental rats [J ] . Tanta Med J , 2019 , 47 ( 2 ): 80 .
岳亚光 , 檀薇薇 , 王文川 , 等 . 二甲双胍经Nrf2-Gpx4通路抑制铁死亡并减轻非酒精性脂肪性肝病大鼠的肝损伤 [J ] . 中国病理生理杂志 , 2021 , 37 ( 10 ): 1848 - 1857 .
李彩艳 , 王东枝 , 张冰 , 等 . 基于瘦素介导的PI3K/AKT通路探讨二甲双胍对脑卒中相关性肺炎大鼠肺损伤的作用机制 [J ] . 中西医结合心脑血管病杂志 , 2024 , 22 ( 9 ): 1604 - 1609 .
彭晓娟 , 钟绿 , 吴楚添 , 等 . 青钱柳多糖和青钱柳黄酮对非酒精性脂肪性肝病合并2型糖尿病模型大鼠血液代谢指标及肝脏病变的影响 [J ] . 中国病理生理杂志 , 2021 , 37 ( 10 ): 1838 - 1847 .
BHARATH L P , NIKOLAJCZYK B S . The intersection of metformin and inflammation [J ] . Am J Physiol Cell Physiol , 2021 , 320 ( 5 ): C873 - C879 .
RUAN G Y , WU F Q , SHI D B , et al . Metformin:update on mechanisms of action on liver diseases [J ] . Front Nutr , 2023 , 10 : 1327814 .
GUO M D , ZHU C H , FU R Z , et al . Ginsenoside Rk3 regulates nonalcoholic steatohepatitis by modulation of intestinal flora and the PI3K/AKT signaling pathway in C57BL/6 mice [J ] . J Agric Food Chem , 2023 , 71 ( 24 ): 9370 - 9380 .
SONG J , QIU H R , DU P , et al . Polyphenols extracted from Shanxi-aged vinegar exert hypolipidemic effects on OA-induced HepG2 cells via the PPARα-LXRα-ABCA1 pathway [J ] . J Food Biochem , 2022 , 46 ( 2 ): e14029 .
郭威 , 李三强 , 宋晓改 , 等 . L-谷氨酰胺对急性酒精肝损伤小鼠的保护作用机制研究 [J ] . 中国临床药理学杂志 , 2020 , 36 ( 13 ): 1812 - 1814 .
DUAN Y M , PAN X F , LUO J Y , et al . Association of inflammatory cytokines with non-alcoholic fatty liver disease [J ] . Front Immunol , 2022 , 13 : 880298 .
FENG Y Y , WANG Z J , PANG H . Role of metformin in inflammation [J ] . Mol Biol Rep , 2023 , 50 ( 1 ): 789 - 798 .
LI J D , WANG T Q , LIU P P , et al . Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD [J ] . Food Funct , 2021 , 12 ( 9 ): 3898 - 3918 .
WALLACE S J , TACKE F , SCHWABE R F , et al . Understanding the cellular interactome of non-alcoholic fatty liver disease [J ] . JHEP Rep , 2022 , 4 ( 8 ): 100524 .
WANG Y F , WANG P Y , YU Y B , et al . Hepatocyte Ninjurin2 promotes hepatic stellate cell activation and liver fibrosis through the IGF1R/EGR1/PDGF-BB signaling pathway [J ] . Metabolism , 2023 , 140 : 155380 .
WANG S , CHEN B H , DU R L , et al . An herbal formulation “Shugan xiaozhi decoction” ameliorates methionine/choline deficiency-induced nonalcoholic steatohepatitis through regulating inflammation and apoptosis-related pathways [J ] . J Ethnopharmacol , 2024 , 329 : 118127 .
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution